EB-001 (botulinum neurotoxin serotype E)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EB-001 (botulinum neurotoxin serotype E), covering 2019-08-05 to 2019-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty [Phase 2]